Title : Signaling pathways in hepatocellular carcinoma.

Pub. Date : 2011

PMID : 22212931






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Molecular therapies such as sorafenib, a BRAF/ VEGFR/PDGFR tyrosine kinase inhibitor, have shown to improve survival in patients with advanced HCC. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens